Business

Covid-19: India frees export of anti-malarial drug Hydroxychloroquine

India on Thursday lifted the restriction on the export of anti-malarial drug Hydroxychloroquine, which is widely used around the world as a prophylactic to fight Covid-19.

migrator

New Delhi

In March, the Centre had imposed curbs on the export of Hydroxychloroquine and formulations used to manufacture the medicine.

According to a late night notification by the Ministry of Commerce and Industry, the export status of the medication and the composition ingredients have been changed from "prohibited" to "free".

The notification was issued by the Directorate General of Foreign Trade (DGFT).

India is a major exporter of Hydroxychloroquine, which has witnessed a surge in demand amid the novel coronavirus crisis.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

E20 policy-reality gap: Public distrustful of government's push for ethanol in petrol, finds Coimbatore study

Free Wi-Fi at Chennai beaches from September; visitors demand stable service

Tambaram: Sanitation workers boycott work over low wages, PF dues

Nationwide tests find E20 petrol meets quality norms, say oil companies rejecting contamination claims

Chennai Citizen Connect: Commuters in a fix as parking for Aadhaar office spills onto bus bay in Anna Nagar